Nuvalent, Inc. Class A Common Stock

NUVL US6707031075

💰
Capitalization
Mid-cap

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

🔗
Website
https://www.nuvalent.com
Annual Performance 1
2021 2022 2023 2024 2025
2% 60% 154% 3% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
310
🙍
Insiders
10
Person Price Shares Total Published Completed
Balcom Alexandra
CFO 		85.43
USD 		19,030
Sold 		1,625,733
USD 		01/10/2025 01/10/2025
Balcom Alexandra
CFO 		86.37
USD 		970
Sold 		83,779
USD 		01/10/2025 01/10/2025
Balcom Alexandra
CFO 		85.43
USD 		19,030
Sold 		1,625,733
USD 		01/10/2025 01/10/2025
Balcom Alexandra
CFO 		86.37
USD 		970
Sold 		83,779
USD 		01/10/2025 01/10/2025
Balcom Alexandra
CFO 		85.06
USD 		20,000
Sold 		1,701,200
USD 		29/09/2025 30/09/2025
Balcom Alexandra
CFO 		85.01
USD 		7,588
Sold 		645,056
USD 		29/09/2025 29/09/2025
Noci Darlene
BDM 		82.33
USD 		522
Sold 		42,976
USD 		29/09/2025 29/09/2025
Noci Darlene
BDM 		84.92
USD 		417
Sold 		35,412
USD 		29/09/2025 29/09/2025
Noci Darlene
BDM 		83.20
USD 		754
Sold 		62,733
USD 		29/09/2025 29/09/2025
Noci Darlene
BDM 		84.53
USD 		1,083
Sold 		91,546
USD 		29/09/2025 29/09/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Nuvalent, Inc. Class A Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-23% -3% -7% 79% 0% 0% 317%
Last 52W Low 52W High All-Time Low All-Time High β
83.38 59.32 104.81 7.40 112.17
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Hack Andrew A. F. 3 174,035,958.59 58,011,986.20 27/03/2024 11/12/2024
Porter James Richard 49 33,287,307.73 679,332.81 15/10/2024 15/09/2025
Shair Matthew 67 32,297,225.80 482,048.15 28/11/2023 24/02/2025
Balcom Alexandra 38 18,506,388.79 487,010.23 18/12/2023 01/10/2025
Noci Darlene 57 12,485,003.46 219,035.15 01/11/2023 29/09/2025
Miller Deborah Ann 46 8,759,099.49 190,415.21 18/12/2023 06/01/2025
Pelish Henry E. 31 8,715,237.32 281,136.69 23/08/2024 10/09/2025
Conley Emily 15 2,826,793.01 188,452.87 15/03/2024 23/08/2024
Protopapas Anna 1 378,350.00 378,350.00 18/12/2023 18/12/2023
Turner Christopher Durant 3 320,009.01 106,669.67 06/01/2025 06/01/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
MERSANA THERAPEUTICS, INC. US59045L1061 MRSN

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.